Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Biochemical Reagents>dBRD9
dBRD9
  • dBRD9

dBRD9 NEW

Price $131 $328 $528
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-09-11

Product Details

Product Name: dBRD9 CAS No.: 2170679-45-3
Purity: 99.81% Supply Ability: 10g
Release date: 2025/09/11

Product Introduction

Bioactivity

NamedBRD9
DescriptiondBRD9 is a PROTAC. dBRD9 is a double-acting molecule, partially containing Bromodomain-containing protein 9 (BRD9), ligand that recruits the cereblon E3 ubiquitin ligase. Ligand that recruits the cereblon E3 ubiquitin ligase. dBRD9 can inhibit the degradation of BRD9 in MOLM-13 cells, and the IC50 is 104 nM.
In vitrodBRD9 has prompt rapid BRD9 degradation over a broad range of concentrations. The degraded BRD9 showed significantly enhanced efficacy(10-to-100-fold). These findings reveal the tractability of non-BET bromodomain-containing proteins to chemical degradation and highlight lead compound dBRD9 as a tool for the study of BRD9[1].
In vivoThe final concentration of dBRD9 of 0.3 nM was mixed in silk fibroin hydrogel and injected into mice. It was found that BRD9 degradant alleviated ZOL-related ONJ. The ONJ-dBRD9 group is filled with well-organized newly formed trabecular bone, with 80% reduced incidence rate of osteonecrosis and periosteal reaction compared with the ONJ-control group[1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 90.0 mg/mL (114.8 mM), Sonication is recommended.
KeywordsPROTAC | dBRD9
Inhibitors RelatedARV-393 HCl | Gefitinib-based PROTAC 3 | ACBI1 | ARV-471 | CCT367766 | dBET6 | dBET1 | Dbet57 | AU-15330 | β-NF-JQ1 | C004019 | GMB-475
Related Compound LibrariesBioactive Compound Library | PPI Inhibitor Library | Bioactive Compounds Library Max

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$197.00/1mg
VIP4Y
TargetMol Chemicals Inc.
2025-09-11
$0.00/100MG
Hubei Chuchang Biotech Co., Ltd.
2024-04-17

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY